부산대학교 도서관

van, de Haar J; Roepman, P; Andre, F; Balmana, J; Castro, E; Chakravarty, D; Curigliano, G; Czarnecka, AM; Dienstmann, R; Horak, P

ANNALS OF ONCOLOGY. 35(11):954-967

Tamborero, D; Dienstmann, R; Rachid, MH; Boekel, J; Lopez-Fernandez, A; Jonsson, M; Razzak, A; Brana, I; De, Petris L; Yachnin, J

NATURE CANCER. 3(2):251-261

Westphalen, CB; Bielo, LB; Aftimos, P; Beltran, H; Benary, M; Chakravarty, D; Collienne, M; Dienstmann, R; Helali, AE; Gainor, J

ANNALS OF ONCOLOGY. 36(6):614-625

Saini KS; Department of Medical Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Martins-Branco D; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Bossi P; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Milan; IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Rozzano, Milan, Italy.; Winther SB; Department of Oncology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Denmark.; Brahmi M; Département d'Oncologie Médicale, Centre Léon Bérard, 69008 Lyon, France.; Braña I; Head and Neck Cancer Group, Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona; Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d´Hebron, Vall d´Hebron Barcelona Hospital Campus, Spain.; Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, 28050 Madrid, Spain.; Castelo-Branco L; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa, Portugal.; Colombo I; Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.; de Azambuja E; Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Medical Oncology Department, Bruxelles, Belgium.; De Ruysscher D; Radiation Oncology (Maastro), Maastricht UMC+, GROW - Research Institute for Oncology and Reproduction, Maastricht; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, The Netherlands.; Dienstmann R; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.; Ekholm M; Department of Oncology, Ryhov County Hospital, Jönköping; Department of Biomedical and Clinical Sciences, Division of Surgery, Orthopedics and Oncology, Linköping University, Linköping, Sweden.; Gallois C; Paris-Cité University, Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Paris, France.; Golfinopoulos V; EORTC Headquarters, Brussels, Belgium.; Grande E; MD Anderson Cancer Center Madrid, Madrid, Spain.; Halabi S; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.; Le Rhun E; Departments of Neurosurgery and Neurology, University Hospital Zurich, Zurich, Switzerland; and Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.; Le Saux O; Département d'Oncologie Médicale, Centre Léon Bérard, 69008 Lyon, France.; Leighl NB; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.; Lonardi S; Oncology Unit 1, Department of Oncology Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.; Lorenzen S; TUM University Hospital, Rechts der Isar, Department of Medicine III, Munich, Germany.; Lorusso D; Division of Gynecologic Oncology Humanitas San Pio X Hospital, Milan and Humanitas University Pieve Emanuele (Milan), Italy.; Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome; IRCCS Neuromed, Pozzilli (IS), Italy.; Mountzios G; Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece.; Oldenburg J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Osterlund P; Department of Oncology, Tampere University Hospital, Tampere, Finland; Department of Oncology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.; Perez-Gracia JL; Department of Oncology and Program in Immunology and Immunotherapy, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain; Centro de Investigacion Biomédica en Red de Cancer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Pellat A; Department of Gastroenterology, endoscopy and digestive oncology, Assistance Publique-Hôpitaux de Paris, Cochin University Hospital, Paris, France.; Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France.; Plummer R; Newcastle University and Newcastle Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Newcastle upon Tyne, UK.; Porta C; Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro', and A.O.U. Consorziale Policlinico di Bari, Bari, Italy.; Punie K; Department of Medical Oncology, Ziekenhuis Aan de Stroom, Antwerp, Belgium.; Ray-Coquard I; Département d'Oncologie Médicale, Centre Léon Bérard, 69008 Lyon, France.; Remon J; Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France.; Ruhlmann CH; Department of Oncology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Denmark.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.; Stacchiotti S; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, via G Venezian 1, 20133 Milano, Italy.; Suarez C; Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d´Hebron, Vall d´Hebron Barcelona Hospital Campus, Spain.; Suijkerbuijk K; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Taieb J; Paris-Cité University, Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Paris, France.; Trapani D; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milano; Early Drug Development for Innovative Therapies Division, European Institute of Oncology, IRCCS, Milan, Italy.; Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro University, Örebro, Sweden.; van Laarhoven HWM; Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Amsterdam; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.; Vogel A; Department of Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, Hannover Medical School, Hannover, Germany; Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.; Zer A; Department of Medical Oncology, Rambam HealthCare Campus, Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.; Pentheroudakis G; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Delaloge S; Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France.; Twelves C; University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Elez E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Siena S; Università degli Studi di Milano, Niguarda Cancer Center and Department of Medical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Sartore-Bianchi A; Università degli Studi di Milano, Niguarda Cancer Center and Department of Medical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Ros J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Ciardello F; Università degli Studi della Campania 'Luigi Vanvitelli', Naples, Italy.; Martinelli E; Università degli Studi della Campania 'Luigi Vanvitelli', Naples, Italy.; Steeghs N; The Netherlands Cancer Institute, Amsterdam, The Netherlands; University Medical Center Utrecht, Utrecht, The Netherlands.; Huijberts S; KU Leuven, Leuven, Belgium; Amsterdam UMC, Amsterdam, The Netherlands.; Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Roselló S; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Tejpar S; UZ Gasthuisberg, Katholieke University Leuven, Leuven, Belgium; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wilmsen B; KU Leuven, Leuven, Belgium; Amsterdam UMC, Amsterdam, The Netherlands.; Salazar R; Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.; Santos C; Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.; de Schaetzen G; EORTC Headquarters, Brussels, Belgium.; Muñoz S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Bernards R; UZ Gasthuisberg, Katholieke University Leuven, Leuven, Belgium; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Moreno V; Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and University of Barcelona Institute of Complex Systems (UBICS), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; García-Galera E; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Alemany R; Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.; Gros A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Bardelli A; Department of Oncology, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy.; Arena S; Department of Oncology, University of Torino, Torino, Italy; Candiolo Cancer Institute, FPO-IRCS, Candiolo, Torino, Italy.; Piris A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Chavarría E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Dienstmann R; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; University of Vic - Central University of Catalonia, Vic, Spain.; Tabernero J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: jtabernero@vhio.net.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Mosele, M F; Westphalen, C B; Stenzinger, A; Barlesi, F; Bayle, A; Bièche, I; Bonastre, J; Castro, E; Dienstmann, R; Krämer, A; Czarnecka, A M; Meric-Bernstam, F; Michiels, S; Miller, R; Normanno, N; Reis-Filho, J; Remon, J; Robson, M; Rouleau, E; Scarpa, A; Serrano, C; Mateo, J; André, F

Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain. Electronic address: rdienstmann@vhio.net.; Vivancos A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Aguilar S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Ruiz-Pace F; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Viaplana C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Gonzalez J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Fite B; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Pedrola A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Elez E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Saura C; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Felip E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Macarulla T; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Capdevila J; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Fariñas-Madrid L; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Carles J; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Muñoz-Cosuelo E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Balmaña J; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Braña I; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garralda E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; IOB Institute of Oncology, Quiron Group (Quiron-IOB), Barcelona, Spain.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Salvà F; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Catani G; Department of Gastrointestinal Tumors, Alexander Fleming Institute, Buenos Aires, Argentina.; Saoudi N; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Baraibar I; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ros J; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rodriguez M; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Salvà de Torres C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Alcaraz A; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garcia A; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Comas R; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ruiz-Pace F; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rezqallah A; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Dienstmann R; ODysSey Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Elez E; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9919053637606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2949-8198 (Electronic) Linking ISSN: 29498198 NLM ISO Abbreviation: ESMO Gastrointest Oncol Subsets: PubMed not MEDLINE

Ros J; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Navarro V; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Villacampa G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Baraibar I; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Salvà F; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rodriguez M; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vaghi C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garcia A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Alcaraz A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Élez E; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9919053637606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2949-8198 (Electronic) Linking ISSN: 29498198 NLM ISO Abbreviation: ESMO Gastrointest Oncol Subsets: PubMed not MEDLINE

Cerna, JGY; Mirallas, O; Puerto, DAG; Velilla, G; Garces, VN; Puga, TG; Monino, AM; Vaz-Salgado, MA; Lopez-Valbuena, D; Gonzalez, AH; Sorolla, MA; Rodriguez, MG; Martínez-García, M; Galceran, JC; Balana, C; Villacampa, G; Dienstmann, R; Pineda, E; Sepúlveda, JM; Vieito, M

Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Martens, UM; Le Tourneau, C; Hackshaw, A; Blay, JY; Geissler, J; Turnbull, C; Schirghuber, E; Skatkova, O; von Meyenn, M; Dienstmann, R

22. Deutscher Kongress für Versorgungsforschung (DKVF); 20231004-20231006; Berlin; DOC23dkvf040 /20231002/

Dienstmann R; Oncology Data Science, Vall d´Hebron Institute of Oncology, Barcelona, Spain; OC Precision Medicine, Oncoclínicas & Co, São Paulo, Brazil; University of Vic-Central University of Catalonia, Barcelona, Spain. Electronic address: https://twitter.com/rdienstmann.; Ruiz-García E; Departamento de Tumores de Tubo Digestivo, Instituto Nacional de Cancerología, Mexico City, Mexico; Laboratorio de Medicina Traslacional, Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: https://twitter.com/Ruiz-García.; Alsina M; Medical Oncology Department, Vall d`Hebron Institute of Oncology, Barcelona, Spain; Hospital Universitario de Navarra, Navarrabiomed-IdiSNA, Pamplona, Spain. Electronic address: https://twitter.com/Alsina.; Ruiz-Pace F; Oncology Data Science, Vall d´Hebron Institute of Oncology, Barcelona, Spain. Electronic address: https://twitter.com/Ruiz-Pace.; Groen-van Schooten TS; Department of Medical Oncology, Amsterdam University Medical Center (UMC), location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Martínez-Ciarpaglini C; Department of Pathology, Hospital Clínico Universitario de Valencia, Valencia, Spain. Electronic address: https://twitter.com/Martínez-Ciarpaglini.; Fernández-Figueroa EA; Núcleo B de Innovación en Medicina de Precisión, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.; Herrera-Goepfert R; Department of Pathology, Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: https://twitter.com/Herrera-Goepfert.; Díaz-Romero C; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: https://twitter.com/Díaz-Romero.; Lino-Silva L; Department of Head of Division, Surgical Pathology, National Cancer Institute (INCan), Mexico City, Mexico. Electronic address: https://twitter.com/Lino-Silva.; Hernandez-Guerrero AI; Department of Gastrointestinal Endoscopy, Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: https://twitter.com/Hernandez-Guerrero.; Valdez-Reyes NM; Laboratorio de Medicina Traslacional, Instituto Nacional de Cancerología, Mexico City, Mexico.; León-Takahashi A; Departamento de Gastroenterología, Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: https://twitter.com/León-Takahashi.; Falcón-Martínez JC; Laboratorio de Medicina Traslacional, Instituto Nacional de Cancerología, Mexico City, Mexico.; Pouw RE; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center (UMC), location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Romero S; Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain. Electronic address: https://twitter.com/Romero.; Villagrasa R; Department of Gastroenterology, Hospital Clínico Universitario de Valencia, Valencia, Spain. Electronic address: https://twitter.com/Villagrasa.; Cabeza-Segura M; Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain. Electronic address: https://twitter.com/Cabeza-Segura.; Alarcón-Molero L; Department of Pathology, Hospital Clínico Universitario de Valencia, Valencia, Spain; Department of Pathology, Hospital General de Valdepeñas, Valdepeñas, Spain. Electronic address: https://twitter.com/Alarcón-Molero.; Jimenez-Martí E; Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain. Electronic address: https://twitter.com/Jimenez-Martí.; Miralles A; Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.; Boggino H; Department of Pathology, GENPAT, Asunción, Paraguay.; Gauna C; Department of Medical Oncology, Instituto de Previsión Social, Asunción, Paraguay.; Pereira R; Department of Medical Oncology, Instituto de Previsión Social, Asunción, Paraguay.; Lezcano H; Department of Pathology, Instituto de Previsión Social, Asunción, Paraguay.; Cantero D; Department of Gastroenterology, Instituto de Previsión Social, Asunción, Paraguay.; Vivancos A; Cancer Genomics Lab, Vall d`Hebron Institute of Oncology, Barcelona, Spain. Electronic address: https://twitter.com/Vivancos.; Matito J; Cancer Genomics Lab, Vall d`Hebron Institute of Oncology, Barcelona, Spain. Electronic address: https://twitter.com/Matito.; Martin A; Cancer Genomics Lab, Vall d`Hebron Institute of Oncology, Barcelona, Spain. Electronic address: https://twitter.com/Martin.; Gómez M; Cancer Genomics Lab, Vall d`Hebron Institute of Oncology, Barcelona, Spain. Electronic address: https://twitter.com/Gómez.; Castillo E; Cancer Genomics Lab, Vall d`Hebron Institute of Oncology, Barcelona, Spain. Electronic address: https://twitter.com/Castillo.; Vila M; Cancer Genomics Lab, Vall d`Hebron Institute of Oncology, Barcelona, Spain. Electronic address: https://twitter.com/Vila.; Ferreira RM; IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. Electronic address: https://twitter.com/Ferreira.; Barros R; IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Pathology, Unidade Local de Saúde São João, Porto, Portugal.; Santos-Antunes J; IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Gastroenterology, Unidade Local de Saúde São João, Porto, Portugal. Electronic address: https://twitter.com/Santos-Antunes.; Mendes-Rocha M; IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Faculty of Medicine of the University of Porto, Porto, Portugal. Electronic address: https://twitter.com/Mendes-Rocha.; Costa A; Department of Oncology, Unidade Local de Saúde São João, Porto, Portugal.; Riquelme E; Department of Respiratory Diseases, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Roa JC; Department of Pathology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Latorre G; Department of Gastroenterology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Freile B; Department of Medical Oncology Department, Instituto Alexander Fleming, Buenos Aires, Argentina.; Caro L; Department of Gastroenterology, Instituto Alexander Fleming, GEDYT (Gastroenterologia diagnostica y terapeutica), Buenos Aires, Argentina.; Esteso F; Department of Medical Oncology Department, Instituto Alexander Fleming, Buenos Aires, Argentina. Electronic address: https://twitter.com/federico_esteso.; O'Connor J; Department of Medical Oncology Department, Instituto Alexander Fleming, Buenos Aires, Argentina. Electronic address: https://twitter.com/juanmaoconnor.; Riquelme A; Department of Gastroenterology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Center for Prevention and Control of Cancer (CECAN), Santiago, Chile.; Owen G; Faculty of Biological Sciences & Faculty of Medicine, Pontificia Universidad Católica de Chile, Millennium Institute for Immunology and Immunotherapy, Center for Prevention and Control of Cancer (CECAN), Advance Center for Chronic Disease (ACCDIS), Santiago, Chile.; Garrido M; Facultad de Medicina y Ciencia de la Salud, Centro de Oncología de Precision, Universidad Mayor, Santiago, Chile. Electronic address: https://twitter.com/DrGarridoOncoGI.; Diez-García M; Medical Oncology Department, Vall d`Hebron Institute of Oncology, Barcelona, Spain. Electronic address: https://twitter.com/Diez-García.; Figueiredo C; IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Faculty of Medicine of the University of Porto, Porto, Portugal. Electronic address: https://twitter.com/FigeuiredoCeu.; Caballero C; Department of Pathology, GENPAT, Asunción, Paraguay.; Lordick F; Department of Oncology and University Cancer Center Leipzig, University of Leipzig Medical Center, Leipzig, Germany. Electronic address: https://twitter.com/FlorianLordick.; Farrés J; Anaxomics Biotech S.L., Barcelona, Spain.; Derks S; Department of Medical Oncology, Amsterdam University Medical Center (UMC), location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Electronic address: https://twitter.com/derks_s.; Carneiro F; IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Pathology, Unidade Local de Saúde São João, Porto, Portugal. Electronic address: https://twitter.com/Carneiro.; Cervantes A; Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain; Ciberonc, Instituto Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.; Fleitas T; Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain; Ciberonc, Instituto Carlos III, Madrid, Spain. Electronic address: tfleitas@incliva.es.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Dienstmann R; OC Precision Medicina, Oncoclínicas & Co, São Paulo, Brazil.; PhD Program, Doctoral School, University of Vic-Central University of Catalonia, Barcelona, Spain.; Oncology Data Science, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.; Blay JY; Centre Léon Bérard and Université Claude Bernard, Lyon, France.; Le Tourneau C; Institut Curie, Department of Drug Development and Innovation (D3i), Paris-Saclay University, Paris, France.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9919053637506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2949-8201 (Electronic) Linking ISSN: 29498201 NLM ISO Abbreviation: ESMO Real World Data Digit Oncol Subsets: PubMed not MEDLINE

Sveen, A; Cremolini, C; Dienstmann, R

Annals of Oncology. Nov2019, Vol. 30 Issue 11, p1682-1685. 4p. 1 Diagram, 1 Chart.

Dienstmann, R; Villacampa, G; Sveen, A; Mason, M J; Niedzwiecki, D; Nesbakken, A; Moreno, V; Warren, R S; Lothe, R A; Guinney, J

Annals of Oncology. Oct2019, Vol. 30 Issue 10, p1622-1629. 8p. 2 Charts, 2 Graphs.

Bartels, M; Chibaudel, B; Dienstmann, R; Lehtiö, J; Piccolo, A; Michielin, O; O'Kane, G; Pruneri, G

CANCERS. 16(16):2888-2888

Ros J; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Matito J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Villacampa G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; The Institute of Cancer Research, London, UK.; Comas R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garcia A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Martini G; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.; Baraibar I; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Saoudi N; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Salvà F; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Martin Á; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain.; Antista M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.; Toledo R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Martinelli E; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.; Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.; Boccaccino A; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.; Cremolini C; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.; Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vivancos A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Elez E; Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: meelez@vhio.net.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE; PubMed not MEDLINE

Mateo, J; Chakravarty, D; Dienstmann, R; Jezdic, S; Gonzalez-Perez, A; Lopez-Bigas, N; Ng, C K Y; Bedard, P L; Tortora, G; Douillard, J -Y

Annals of Oncology. Sep2018, Vol. 29 Issue 9, p1895-1902. 8p. 3 Charts.

Smeby, J; Sveen, A; Merok, M A; Danielsen, S A; Eilertsen, I A; Guren, M G; Dienstmann, R; Nesbakken, A; Lothe, R A

Annals of Oncology. May2018, Vol. 29 Issue 5, p1227-1234. 8p. 2 Charts, 2 Graphs.

Tamborero, D; Dienstmann, R; Rachid, MH; Boekel, J; Baird, R; Brana, I; De, Petris L; Yachnin, J; Massard, C; Opdam, FL

NATURE MEDICINE. 26(7):992-994